| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0092-8674(88)90463-1 |
| P698 | PubMed publication ID | 3342447 |
| P50 | author | Helen Blau | Q15989699 |
| P2093 | author name string | Silberstein L | |
| Hays AP | |||
| Webster C | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 503-513 | |
| P577 | publication date | 1988-02-01 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. | |
| P478 | volume | 52 |
| Q44656006 | "mdx" mouse myopathy: histopathological, morphometric and histochemical observations on young mice |
| Q93216909 | A 96-well culture platform enables longitudinal analyses of engineered human skeletal muscle microtissue strength |
| Q40327155 | A Twist2-dependent progenitor cell contributes to adult skeletal muscle |
| Q35207780 | A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type |
| Q100751533 | A defined N6-methyladenosine (m6A) profile conferred by METTL3 regulates muscle stem cell/myoblast state transitions |
| Q33287220 | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre |
| Q36177601 | A short-term statin treatment changes the contractile properties of fast-twitch skeletal muscles |
| Q36283668 | AMP-activated protein kinase stimulates Warburg-like glycolysis and activation of satellite cells during muscle regeneration |
| Q47781006 | AMPK in skeletal muscle function and metabolism. |
| Q36422465 | Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy. |
| Q34633239 | Absence of developmental and unconventional myosin heavy chain in human suprahyoid muscles |
| Q52927863 | Absolute quantification of myosin heavy chain isoforms by selected reaction monitoring can underscore skeletal muscle changes in a mouse model of amyotrophic lateral sclerosis. |
| Q36968852 | Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury. |
| Q35924888 | Altered Energetics of Exercise Explain Risk of Rhabdomyolysis in Very Long-Chain Acyl-CoA Dehydrogenase Deficiency |
| Q34335939 | Altered cross-bridge properties in skeletal muscle dystrophies |
| Q36581372 | Analysis of the ACTN3 heterozygous genotype suggests that α-actinin-3 controls sarcomeric composition and muscle function in a dose-dependent fashion |
| Q45069467 | Anisotropic mechanosensitive pathways in the diaphragm and their implications in muscular dystrophies |
| Q45073133 | Are mice good models for human neuromuscular disease? Comparing muscle excursions in walking between mice and humans |
| Q77989755 | Are motoneurons involved in muscular dystrophy? |
| Q37295847 | Association of a single nucleotide polymorphism in the 5' upstream region of the porcine myosin heavy chain 4 gene with meat quality traits in pigs |
| Q52485843 | Association of dystrophin and an integral membrane glycoprotein. |
| Q28211597 | Association of neuronal nitric oxide synthase (nNOS) with alpha1-syntrophin at the sarcolemma |
| Q37589572 | Autonomic dysfunction in muscular dystrophy: a theoretical framework for muscle reflex involvement. |
| Q27320555 | CREB is activated by muscle injury and promotes muscle regeneration |
| Q36327575 | Calcineurin activity is required for the initiation of skeletal muscle differentiation |
| Q46603395 | Calcium entry through stretch-inactivated ion channels in mdx myotubes |
| Q89597200 | Calmodulin-Binding Proteins in Muscle: A Minireview on Nuclear Receptor Interacting Protein, Neurogranin, and Growth-Associated Protein 43 |
| Q42835796 | Cell fractionation studies indicate that dystrophin is a protein of surface membranes of skeletal muscle |
| Q34001045 | Circulating Muscle-specific miRNAs in Duchenne Muscular Dystrophy Patients |
| Q34429838 | Combined effect of AMPK/PPAR agonists and exercise training in mdx mice functional performance |
| Q43717688 | Comparative evolution of muscular dystrophy in diaphragm, gastrocnemius and masseter muscles from old male mdx mice |
| Q46388856 | Comparison of the myoplasmic calcium transient elicited by an action potential in intact fibres of mdx and normal mice |
| Q92854049 | Comprehensive Analysis of lncRNAs and circRNAs Reveals the Metabolic Specialization in Oxidative and Glycolytic Skeletal Muscles |
| Q44473148 | Consequence of parvalbumin deficiency in the mdx mouse: histological, biochemical and mechanical phenotype of a new double mutant. |
| Q45906713 | Contractility and kinetics of human fetal and human adult skeletal muscle. |
| Q26823743 | Control of muscle fibre-type diversity during embryonic development: the zebrafish paradigm |
| Q37307474 | Coupling of mitochondrial function and skeletal muscle fiber type by a miR-499/Fnip1/AMPK circuit |
| Q46588754 | Deficiency of alpha-sarcoglycan differently affects fast- and slow-twitch skeletal muscles |
| Q36202892 | Deletion of integrin-linked kinase from skeletal muscles of mice resembles muscular dystrophy due to alpha 7 beta 1-integrin deficiency |
| Q90100663 | Depletion of HuR in murine skeletal muscle enhances exercise endurance and prevents cancer-induced muscle atrophy |
| Q24604904 | Designing materials to direct stem-cell fate |
| Q34349806 | Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2. |
| Q28584710 | Differential Association of Syntrophin Pairs with the Dystrophin Complex |
| Q28564299 | Differential distribution of dystrophin and beta-spectrin at the sarcolemma of fast twitch skeletal muscle fibers |
| Q35588699 | Disease course in mdx:utrophin+/- mice: comparison of three mouse models of Duchenne muscular dystrophy |
| Q48667129 | Disorders of Sleep and Breathing during Sleep in Neuromuscular Disease |
| Q52626168 | Disruption of muscle renin-angiotensin system in AT1a-/- mice enhances muscle function despite reducing muscle mass but compromises repair after injury. |
| Q74535886 | Distinct mechanisms regulate slow-muscle development |
| Q37002690 | Distinct populations of adipogenic and myogenic Myf5-lineage progenitors in white adipose tissues. |
| Q43876648 | Distinctive patterns of basic fibroblast growth factor (bFGF) distribution in degenerating and regenerating areas of dystrophic (mdx) striated muscles |
| Q42479484 | Distribution of ten laminin chains in dystrophic and regenerating muscles |
| Q48690770 | Duane retraction syndrome in a patient with Duchenne muscular dystrophy |
| Q52422017 | Duchenne muscular dystrophy quantification: a multivariate analysis of surface EMG |
| Q38257886 | Dysregulation of calcium homeostasis in muscular dystrophies. |
| Q60178239 | Dystrophin abnormalities in Duchenne and Becker dystrophy carriers: correlation with cytoskeletal proteins and myosins |
| Q38198560 | Dystrophin and the integrity of the sarcolemma in Duchenne muscular dystrophy |
| Q36531459 | Dystrophin colocalizes with beta-spectrin in distinct subsarcolemmal domains in mammalian skeletal muscle |
| Q33313653 | Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle |
| Q42755001 | Dystrophin deficiency is associated with myotendinous junction defects in prenecrotic and fully regenerated skeletal muscle. |
| Q37657101 | Dystrophin insufficiency causes selective muscle histopathology and loss of dystrophin-glycoprotein complex assembly in pig skeletal muscle. |
| Q36259954 | Dystrophin protects the sarcolemma from stresses developed during muscle contraction |
| Q43107646 | Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma |
| Q38365284 | Dystrophin-related muscular dystrophies |
| Q36142090 | E2F transcription factor-1 deficiency reduces pathophysiology in the mouse model of Duchenne muscular dystrophy through increased muscle oxidative metabolism |
| Q47377667 | EDL and soleus muscles of the C57BL6J/dy2j laminin-alpha 2-deficient dystrophic mouse are not vulnerable to eccentric contractions |
| Q92967182 | ERK1/2 signaling induces skeletal muscle slow fiber-type switching and reduces muscular dystrophy disease severity |
| Q36977749 | Early mechanical dysfunction of the diaphragm in the muscular dystrophy with myositis (Ttnmdm) model |
| Q34489678 | Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy |
| Q55193807 | Elevated GLUT4 and glycogenin protein abundance correspond to increased glycogen content in the soleus muscle of mdx mice with no benefit associated with taurine supplementation. |
| Q33814359 | Endogenous nitric oxide synthesis: biological functions and pathophysiology |
| Q91933575 | Evaluation of Yanagihara facial nerve grading system based on a muscle fiber analysis of human facial muscles |
| Q37622616 | Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy |
| Q52165729 | Evidence for differential post-translational modifications of slow myosin heavy chain during murine skeletal muscle development. |
| Q36233237 | Evidence for myoblast-extrinsic regulation of slow myosin heavy chain expression during muscle fiber formation in embryonic development |
| Q47995990 | Examining potential drug therapies for muscular dystrophy utilising the dy/dy mouse: I. Clenbuterol |
| Q38111711 | Exercise and muscular dystrophy: implications and analysis of effects on musculoskeletal and cardiovascular systems |
| Q24339562 | Expression and DNA sequence analysis of a human embryonic skeletal muscle myosin heavy chain gene |
| Q52238875 | Expression of myosin heavy chain isoforms in Duchenne muscular dystrophy patients and carriers |
| Q38330554 | Expression of specific white adipose tissue genes in denervation-induced skeletal muscle fatty degeneration. |
| Q28513736 | Expression of utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated by calcineurin/NFAT signaling |
| Q36293416 | Extensive but coordinated reorganization of the membrane skeleton in myofibers of dystrophic (mdx) mice |
| Q50506362 | Extraocular muscle is spared despite the absence of an intact sarcoglycan complex in gamma- or delta-sarcoglycan-deficient mice. |
| Q40474236 | Extraocular muscles: Basic and clinical aspects of structure and function |
| Q34539583 | Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1) is a dynamic nuclear and sarcomeric protein |
| Q84786967 | Fiber Type Composition of the Sternomastoid and Diaphragm Muscles of Dystrophin‐Deficient mdx Mice |
| Q42446242 | Fibre type-specific satellite cell content in two models of muscle disease. |
| Q72694744 | Fibres of intermediate type 1C and 2C are found continuously in mdx soleus muscle up to 52 weeks |
| Q34985419 | Fnip1 regulates skeletal muscle fiber type specification, fatigue resistance, and susceptibility to muscular dystrophy |
| Q34045389 | Genome-wide mapping of Sox6 binding sites in skeletal muscle reveals both direct and indirect regulation of muscle terminal differentiation by Sox6. |
| Q58716353 | Guanidinoacetic Acid Regulates Myogenic Differentiation and Muscle Growth Through miR-133a-3p and miR-1a-3p Co-mediated Akt/mTOR/S6K Signaling Pathway |
| Q34642974 | Hindlimb skeletal muscle function in myostatin-deficient mice. |
| Q41150457 | Human dental pulp pluripotent-like stem cells promote wound healing and muscle regeneration |
| Q34548762 | Human embryonic myosin heavy chain cDNA. Interspecies sequence conservation of the myosin rod, chromosomal locus and isoform specific transcription of the gene |
| Q24601142 | Huntingtin-associated protein (HAP1): discrete neuronal localizations in the brain resemble those of neuronal nitric oxide synthase |
| Q35158172 | Hyperpolarized functional magnetic resonance of murine skeletal muscle enabled by multiple tracer-paradigm synchronizations |
| Q83178102 | Hypertrophic muscle fibers with fissures in power-lifters; fiber splitting or defect regeneration? |
| Q24300282 | Identification of three developmentally controlled isoforms of human myosin heavy chains |
| Q36760419 | Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle |
| Q41522698 | Improvements in motor tasks through the use of smartphone technology for individuals with Duchenne muscular dystrophy. |
| Q88479019 | In Vitro Tissue-Engineered Skeletal Muscle Models for Studying Muscle Physiology and Disease |
| Q44826878 | Increased sarcolipin expression and decreased sarco(endo)plasmic reticulum Ca2+ uptake in skeletal muscles of mouse models of Duchenne muscular dystrophy |
| Q72102757 | Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch |
| Q41096343 | Influence of Botulinumtoxin A on the Expression of Adult MyHC Isoforms in the Masticatory Muscles in Dystrophin-Deficient Mice (Mdx-Mice). |
| Q92251782 | Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy |
| Q42778011 | Insights into interplay between rexinoid signaling and myogenic regulatory factor-associated chromatin state in myogenic differentiation. |
| Q46528995 | Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage |
| Q37233110 | Lamina-associated polypeptide-1 interacts with the muscular dystrophy protein emerin and is essential for skeletal muscle maintenance |
| Q100559530 | Lifetime analysis of mdx skeletal muscle reveals a progressive pathology that leads to myofiber loss |
| Q47288511 | Link between MHC Fiber Type and Restoration of Dystrophin Expression and Key Components of the DAPC by Tricyclo-DNA-Mediated Exon Skipping |
| Q46736335 | Localization of muscle gene products in nuclear domains |
| Q58985911 | Localizing the gene product |
| Q58590513 | Long-term effectiveness of local BM-MSCs for skeletal muscle regeneration: a proof of concept obtained on a pig model of severe radiation burn |
| Q36580725 | Loss of cIAP1 attenuates soleus muscle pathology and improves diaphragm function in mdx mice |
| Q33829626 | Lymphocyte antigen Leu-19 as a molecular marker of regeneration in human skeletal muscle |
| Q33556205 | Making fast-twitch dystrophic muscles bigger protects them from contraction injury and attenuates the dystrophic pathology |
| Q38717697 | Mass spectrometry-based protein analysis to unravel the tissue pathophysiology in Duchenne muscular dystrophy |
| Q43300125 | Masticatory (;superfast') myosin heavy chain and embryonic/atrial myosin light chain 1 in rodent jaw-closing muscles |
| Q24310000 | Maximum velocity of shortening in relation to myosin isoform composition in single fibres from human skeletal muscles |
| Q33680413 | Mechanisms of resistance to pathogenesis in muscular dystrophies |
| Q26772002 | Metabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular Dystrophy |
| Q28546070 | Metabolic dysfunction and altered mitochondrial dynamics in the utrophin-dystrophin deficient mouse model of duchenne muscular dystrophy |
| Q35142864 | Mice lacking microRNA 133a develop dynamin 2–dependent centronuclear myopathy |
| Q33685967 | MicroRNA-486-dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptoms |
| Q37781219 | MicroRNAs in skeletal muscle: their role and regulation in development, disease and function. |
| Q64229243 | Mitochondrial oxidative stress impairs contractile function but paradoxically increases muscle mass via fibre branching |
| Q90407716 | Modeling disease trajectory in Duchenne muscular dystrophy |
| Q36007403 | Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice |
| Q37799373 | Molecular Mechanisms and Treatment Options for Muscle Wasting Diseases |
| Q47365380 | Molecular analysis of fiber type-specific expression of murine myostatin promoter |
| Q24339451 | Molecular genetic characterization of a developmentally regulated human perinatal myosin heavy chain |
| Q37438488 | Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy |
| Q73846345 | Morphological variability and specializations in bovine extraocular muscle spindles |
| Q74619520 | Motoneurons are altered in muscular dystrophy |
| Q34470065 | Multiple regulatory events controlling the expression and localization of utrophin in skeletal muscle fibers: insights into a therapeutic strategy for Duchenne muscular dystrophy |
| Q73963797 | Muscle and joint elastic properties during elbow flexion in Duchenne muscular dystrophy |
| Q34698722 | Muscle fiber type-predominant promoter activity in lentiviral-mediated transgenic mouse |
| Q27314850 | Muscle-specific SIRT1 gain-of-function increases slow-twitch fibers and ameliorates pathophysiology in a mouse model of duchenne muscular dystrophy |
| Q28593015 | Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation |
| Q42514805 | Muscular nitric oxide synthase (muNOS) and utrophin |
| Q35149124 | Myo/Nog cells: targets for preventing the accumulation of skeletal muscle-like cells in the human lens. |
| Q41426747 | Myofiber-specific TEAD1 overexpression drives satellite cell hyperplasia and counters pathological effects of dystrophin deficiency. |
| Q34627033 | Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice |
| Q52243465 | Myosin heavy and light chain expression during human skeletal muscle development and precocious muscle maturation induced by thyroid hormone. |
| Q57390406 | Myotonic ADR-MDX mutant mice show less severe muscular dystrophy than MDX mice1Part of this work was presented at the meeting of the German Physiological Society in Rostock, March 1997.1 |
| Q36084108 | NO skeletal muscle derived relaxing factor in Duchenne muscular dystrophy |
| Q38630255 | Natural disease history of mouse models for limb girdle muscular dystrophy types 2D and 2F |
| Q41100326 | Nitric oxide signaling in the nervous system |
| Q24307833 | Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy |
| Q34348841 | Nitric oxide: biologic effects on muscle and role in muscle diseases |
| Q40240062 | Notochord induction of zebrafish slow muscle mediated by Sonic hedgehog. |
| Q28480452 | Novel approach to meta-analysis of microarray datasets reveals muscle remodeling-related drug targets and biomarkers in Duchenne muscular dystrophy |
| Q36272908 | Nur77 deletion impairs muscle growth during developmental myogenesis and muscle regeneration in mice. |
| Q89767037 | Nutritional intervention with cyanidin hinders the progression of muscular dystrophy |
| Q38973118 | PTRH2 gene mutation causes progressive congenital skeletal muscle pathology |
| Q35673713 | Pathogenesis of Duchenne muscular dystrophy: the calcium hypothesis revisited |
| Q64062716 | Peptide YY (PYY) Is Expressed in Human Skeletal Muscle Tissue and Expanding Human Muscle Progenitor Cells |
| Q84829768 | Peroxisome proliferator-activated receptor γ coactivator1- gene α transfer restores mitochondrial biomass and improves mitochondrial calcium handling in post-necrotic mdx mouse skeletal muscle |
| Q34152280 | Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials |
| Q55366811 | Phenotype-Specific Response of Circulating miRNAs Provides New Biomarkers of Slow or Fast Muscle Damage. |
| Q33651574 | Physical training in boys with Duchenne Muscular Dystrophy: the protocol of the No Use is Disuse study |
| Q68752136 | Physiological properties of skinned fibres from normal and dystrophic (Duchenne) human muscle activated by Ca2+ and Sr2+ |
| Q35974809 | Porcine models of muscular dystrophy |
| Q41911490 | Post-natal induction of PGC-1α protects against severe muscle dystrophy independently of utrophin. |
| Q52177002 | Postnatal development of myosin heavy chain isoforms in rat laryngeal muscles. |
| Q28544401 | Pregnancy-induced amelioration of muscular dystrophy phenotype in mdx mice via muscle membrane stabilization effect of glucocorticoid |
| Q38820669 | Progressive muscle proteome changes in a clinically relevant pig model of Duchenne muscular dystrophy |
| Q34632522 | Properties of enzymatically isolated skeletal fibres from mice with muscular dystrophy |
| Q43884201 | Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice. |
| Q51664676 | Proteomic profiling of muscle fibre type shifting in neuromuscular diseases. |
| Q30983066 | Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy. |
| Q44810912 | Quantitative analysis of dystrophin in fast- and slow-twitch mammalian skeletal muscle |
| Q38391853 | Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells. |
| Q36283290 | RNA-seq and metabolomic analyses of Akt1-mediated muscle growth reveals regulation of regenerative pathways and changes in the muscle secretome |
| Q52174399 | Rat embryonic myoblasts are restricted to forming primary fibres while later myogenic populations are pluripotent. |
| Q64103104 | Regulation of the dystrophin-associated glycoprotein complex composition by the metabolic properties of muscle fibres |
| Q27310125 | Rescue of dystrophic skeletal muscle by PGC-1α involves a fast to slow fiber type shift in the mdx mouse |
| Q26748160 | Resveratrol and Myopathy |
| Q33840129 | Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1α axis |
| Q26748736 | SIRT1: A Novel Target for the Treatment of Muscular Dystrophies |
| Q45023028 | SNF-6 is an acetylcholine transporter interacting with the dystrophin complex in Caenorhabditis elegans |
| Q39592811 | Saccadic eye movements are impaired in Duchenne muscular dystrophy. |
| Q51829611 | Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1. |
| Q35924068 | Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies. |
| Q41019141 | Severe murine limb-girdle muscular dystrophy type 2C pathology is diminished by FTY720 treatment |
| Q36246691 | Short-term, high-fat diet accelerates disuse atrophy and protein degradation in a muscle-specific manner in mice |
| Q79086242 | Significant differences among skeletal muscles in the incorporation of bone marrow-derived cells |
| Q42652757 | Silencing Nfix rescues muscular dystrophy by delaying muscle regeneration |
| Q55515149 | Skeletal Muscle Metabolism in Duchenne and Becker Muscular Dystrophy-Implications for Therapies. |
| Q47874181 | Skeletal muscle contractile properties in a novel murine model for limb girdle muscular dystrophy 2i. |
| Q37529679 | Skeletal muscle fiber type: using insights from muscle developmental biology to dissect targets for susceptibility and resistance to muscle disease |
| Q37719612 | Skeletal muscle fibre diversity and the underlying mechanisms. |
| Q90947313 | Skeletal muscle mitochondrial remodeling in exercise and diseases |
| Q92689430 | Sonic Hedgehog upregulation does not enhance the survival and engraftment of stem cell-derived cardiomyocytes in infarcted hearts |
| Q41634914 | Spatial and age-related changes in the microstructure of dystrophic and healthy diaphragms |
| Q38649230 | Spatially localized phosphorous metabolism of skeletal muscle in Duchenne muscular dystrophy patients: 24-month follow-up |
| Q82391386 | Specificity of different anti-myosin heavy chain antibodies in bovine muscle |
| Q52621969 | Splitting of Pi and other ³¹P NMR anomalies of skeletal muscle metabolites in canine muscular dystrophy. |
| Q46805060 | Stimulation of calcineurin Aalpha activity attenuates muscle pathophysiology in mdx dystrophic mice. |
| Q51928332 | Stra13 regulates oxidative stress mediated skeletal muscle degeneration. |
| Q36407033 | Stressed out: the skeletal muscle ryanodine receptor as a target of stress |
| Q59690733 | Structural and functional alterations of muscle fibres in the novel mouse model of facioscapulohumeral muscular dystrophy |
| Q43819573 | Sympathetic modulation of renal blood flow by rilmenidine and captopril: central vs. peripheral effects |
| Q36874154 | Synergizing Engineering and Biology to Treat and Model Skeletal Muscle Injury and Disease. |
| Q59092417 | TDP-43 and RNA form amyloid-like myo-granules in regenerating muscle |
| Q64957976 | The "Usual Suspects": Genes for Inflammation, Fibrosis, Regeneration, and Muscle Strength Modify Duchenne Muscular Dystrophy. |
| Q64928324 | The Effect of Vitamin D Supplementation on Skeletal Muscle in the mdx Mouse Model of Duchenne Muscular Dystrophy. |
| Q46174173 | The ascorbic acid transporter SVCT2 is expressed in slow-twitch skeletal muscle fibres |
| Q58438337 | The cardiac isoform of α-actin in regenerating and atrophic skeletal muscle, myopathies and rhabdomyomatous tumors: an immunohistochemical study using monoclonal antibodies |
| Q35784455 | The embryonic myosin R672C mutation that underlies Freeman-Sheldon syndrome impairs cross-bridge detachment and cycling in adult skeletal muscle |
| Q42862568 | The expression of glycogen phosphorylase in normal and dystrophic muscle |
| Q59051261 | The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy |
| Q35848770 | The membrane hypothesis of Duchenne muscular dystrophy: quest for functional evidence |
| Q41738877 | The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy |
| Q91105830 | The panniculus carnosus muscle: A novel model of striated muscle regeneration that exhibits sex differences in the mdx mouse |
| Q35057120 | The passive mechanical properties of the extensor digitorum longus muscle are compromised in 2- to 20-mo-old mdx mice |
| Q89017143 | The regulation of skeletal muscle fiber-type composition by betaine is associated with NFATc1/MyoD |
| Q88453324 | Thick Filament Protein Network, Functions, and Disease Association |
| Q44119998 | TnIfast IRE enhancer: multistep developmental regulation during skeletal muscle fiber type differentiation |
| Q90192716 | Treatment of Dystrophic mdx Mice with an ADAMTS-5 Specific Monoclonal Antibody Increases the Ex Vivo Strength of Isolated Fast Twitch Hindlimb Muscles |
| Q36884990 | Trip12, a HECT domain E3 ubiquitin ligase, targets Sox6 for proteasomal degradation and affects fiber type-specific gene expression in muscle cells |
| Q72798735 | Troponin T is capable of binding dystrophin via a leucine zipper |
| Q69401859 | Ultrastructural changes in skeletal muscle in ovine muscular dystrophy |
| Q33836366 | Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse |
| Q41887615 | Upregulation of the creatine synthetic pathway in skeletal muscles of mature mdx mice |
| Q55070574 | Utrophin A is essential in mediating the functional adaptations of mdx mouse muscle following chronic AMPK activation. |
| Q42634544 | Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle |
| Q40603890 | Validation of ultrasonography for non-invasive assessment of diaphragm function in muscular dystrophy |
| Q39376754 | Why short stature is beneficial in Duchenne muscular dystrophy |
| Q33955159 | iNOS ablation does not improve specific force of the extensor digitorum longus muscle in dystrophin-deficient mdx4cv mice |
| Q35092389 | miR-30 family microRNAs regulate myogenic differentiation and provide negative feedback on the microRNA pathway |
| Q39310461 | nNOS regulation of skeletal muscle fatigue and exercise performance |
| Q35817497 | β1D chain increases α7β1 integrin and laminin and protects against sarcolemmal damage in mdx mice |
Search more.